https://www.modernretina.com/view/olix-pharmaceuticals-announces-positive-results-of-phase-1-study-of-safety-and-tolerability-of-olx10212
0
0
Research results: OliX Pharmaceuticals announces positive results of phase 1 safety and tolerability results of OLX10212 for AMD - Ophthalmology Times Europe
+ 76 more
12/13/23 at 6:25am
Organization
Modernretina.com
Author
Sydney M Crago
Details
34 words
Summarize
Pharmaceuticals & Biotech Health Pharmacy OliX Pharmaceuticals dosing levels OLX10212 AMD - Ophthalmology Times Europe
The study results will help to identify dosing levels for future clinical trials
Create an account or login to join the discussion